Kennedy Capital Management LLC Sells 10,975 Shares of UnitedHealth Group Incorporated $UNH

Kennedy Capital Management LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 51,568 shares of the healthcare conglomerate's stock after selling 10,975 shares during the quarter. Kennedy Capital Management LLC's holdings in UnitedHealth Group were worth $16,088,000 at the end of the most recent quarter.

• 5 Healthcare Names to Watch as Sector Rotation Is in Full Swing

A number of other institutional investors have also recently made changes to their positions in UNH. Vanguard Group Inc. increased its holdings in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. Geode Capital Management LLC raised its position in shares of UnitedHealth Group by 3.3% in the second quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate's stock valued at $6,624,411,000 after purchasing an additional 675,075 shares during the period. Norges Bank bought a new position in UnitedHealth Group in the 2nd quarter worth approximately $3,837,207,000. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of UnitedHealth Group by 6.1% during the second quarter. Charles Schwab Investment Management Inc. now owns 7,502,469 shares of the healthcare conglomerate's stock worth $2,340,346,000 after acquiring an additional 432,084 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

A number of analysts recently issued reports on UNH shares. Truist Financial boosted their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research note on Tuesday, September 9th. KeyCorp increased their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a report on Wednesday, October 8th. Leerink Partners set a $410.00 price objective on shares of UnitedHealth Group and gave the company an "outperform" rating in a research note on Wednesday, October 29th. Zacks Research raised shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a report on Monday, October 6th. Finally, TD Cowen increased their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the stock a "hold" rating in a research report on Thursday, October 30th. Eighteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $397.12.

• Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy

Check Out Our Latest Research Report on UNH

UnitedHealth Group Price Performance

UNH opened at $340.13 on Thursday. The stock has a 50-day moving average price of $342.30 and a 200-day moving average price of $315.70. The stock has a market capitalization of $308.10 billion, a P/E ratio of 17.75, a PEG ratio of 2.11 and a beta of 0.43. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $622.83. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71.

• UnitedHealth Group’s Recovery in Full Swing: Buy While It's Down

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts' consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to analysts' expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business's quarterly revenue was up 12.2% on a year-over-year basis. During the same period last year, the business earned $7.15 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group's dividend payout ratio (DPR) is 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

• Five stocks we like better than UnitedHealth Group
• How to start investing in penny stocks
• MongoDB Just Posted a Blowout Quarter—But Is It Too Hot to Touch?
• Large Cap Stock Definition and How to Invest
• 3 Stocks Poised to Benefit From Google’s AI Breakthough
• 3 Fintech Stocks With Good 2021 Prospects
• Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here